Listen Now

Topics Covered

  • Overview of HER2 Positive Breast Cancer
  • Diagnostic Testing: Grade and Hormone Receptors
  • Standard Treatment Options, including Targeted Therapy
  • Investigational New Drugs in Clinical Trials
  • How Research Contributes to Your Treatment Options
  • Managing Treatment Side Effects
  • Effective Communication with Your Health Care Team
  • Questions for Our Panel of Experts

Our Panel of Experts

Edith A. Perez, MD
Professor of Medicine, Director, Breast Cancer Translational Genomics Program, Deputy Director at Large, Mayo Clinic Cancer Center, Group Vice Chair, Alliance for Clinical Trials in Oncology, Mayo Clinic
Lidia Schapira, MD
Assistant Professor of Medicine, Harvard Medical School, Staff Oncologist, Gillette Center for Breast Cancer, Massachusetts General Hospital
Generosa Grana, MD
Director, Cooper Institute, Head, Division of Hematology-Oncology, Cooper University Hospital, Associate Professor of Medicine, Cooper Medical School of Rowan University
Maria Chi, MSW
Clinical Supervisor, CancerCare


You can download the brochure for this workshop (pdf) (93 KB)

Workshop Date

This workshop was originally recorded on June 19, 2013.

Find More Connect Workshops

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.